PPAI Plans Strategy For Physician Payments Sunshine Act

PPAI has established a strong lobbying presence in Washington, D.C. So far this year, PPAI Board chair-elect Scott Siegel, MAS, traveled to Washington and participated in a town hall meeting in the White House with President Obama. Additionally, members of PPAI staff met with the Consumer Product Safety Commission (CPSC) to address issues with the Consumer Product Safety Improvement Act (CPSIA) that went into effect in 2008, and our lobbyists have been in regular meetings with elected officials regarding bills that could change the way our industry does business. To date, we are monitoring more than 1,200 bills at the state and federal levels-so you don’t have to.

This doesn’t mean members can’t participate in and even help effect policy change. The Physician Payments Sunshine Act, S. 301, is one bill currently before the U.S. Senate that, if passed as written, could effectively ban the distribution of promotional products to healthcare professionals.

S. 301 would require all manufacturers of covered drugs, devices or medical supplies to disclose payments or any other “transfer of value” made to a physician, a physician medical practice or a physician group practice. Promotional products are included in this definition.

If every item must be reported, the reality is many companies will opt to give nothing of value rather than report each item. Regardless of your client base, this bill as it stands could have a staggering economic impact on our industry, on the small business owner and on you.

PPAI urges every member to contact U.S. senators from his or her district and voice opposition to S. 301 in its current form. Visit PPAI LAW at www.capwiz.com/ppa/home/ for a copy of the letter and to locate contact information for senators.

If you are considering using promotional items to promotion your corporation brand, please contact us for more information. We have all of the expertise you’ll need. 

Provided by DMG Promotions.com

Comments are closed.